Holding(s) in Company

Allergy Therapeutics Ltd 15 October 2004 SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Name of company Allergy Therapeutics plc 2. Name of shareholder having a major interest Universities Superannuations Scheme Limited 3. Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18 - 4. Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them UK Smaller Companies registered under Chase Nominees Ltd (USS) 5. Number of shares / amount of stock acquired 2,397,260 6. Percentage of issued class 3.81% 7. Number of shares / amount of stock disposed - 8. Percentage of issued class - 9. Class of security Ordinary shares 10. Date of transaction 12 October 2004 11. Date company informed 14 October 2004 12. Total holding following this notification 2,397,260 13. Total percentage holding of issued class following this notification 3.81% 14. Any additional information - 15. Name of contact and telephone number for queries Ian Postlethwaite - 01903 844721 16. Name and signature of authorised company official responsible for making this notification Ian Postlethwaite Date of notification 15 October 2004 The FSA does not give any express or implied warranty as to the accuracy of this document or material and does not accept any liability for error or omission. The FSA is not liable for any damages (including, without limitation, damages for loss of business or loss of profits) arising in contract, tort or otherwise from the use of or inability to use this document, or any material contained in it, or from any action or decision taken as a result of using this document or any such material. This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings